Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML

Aditi Shastri; Amit K. Verma

doi:10.1016/S2352-3026(17)30229-6

Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML

Aditi Shastri, Amit K. Verma

Oncology

Research output: Contribution to journal › Comment/debate › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	e6-e7
Journal	The Lancet Haematology
Volume	5
Issue number	1
DOIs	https://doi.org/10.1016/S2352-3026(17)30229-6
State	Published - Jan 2018

ASJC Scopus subject areas

Hematology

Access to Document

10.1016/S2352-3026(17)30229-6

Cite this

@article{ecda81a5eb1b4a73a737e94001794740,

title = "Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML",

author = "Aditi Shastri and Verma, {Amit K.}",

year = "2018",

month = jan,

doi = "10.1016/S2352-3026(17)30229-6",

language = "English (US)",

volume = "5",

pages = "e6--e7",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Lancet Publishing Group",

number = "1",

}

TY - JOUR

T1 - Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML

AU - Shastri, Aditi

AU - Verma, Amit K.

PY - 2018/1

Y1 - 2018/1

UR - http://www.scopus.com/inward/record.url?scp=85037733772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037733772&partnerID=8YFLogxK

U2 - 10.1016/S2352-3026(17)30229-6

DO - 10.1016/S2352-3026(17)30229-6

M3 - Comment/debate

C2 - 29241763

AN - SCOPUS:85037733772

SN - 2352-3026

VL - 5

SP - e6-e7

JO - The Lancet Haematology

JF - The Lancet Haematology

IS - 1

ER -

Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this